New Hope for Lung Cancer Patients 7/6/16

Posted at 8:12 AM, Jul 07, 2016
and last updated 2016-07-07 08:12:56-04

Lung Cancer is by far the leading cause of cancer death among men and women, claiming more lives than breast, colon and prostate cancers combined - killing twice as many women as breast cancer. And, one of the biggest misconceptions about lung cancer is that there is not much hope once you are diagnosed. But now amazing advances in lung cancer treatments are helping to change the outcomes and providing much needed hope for all diagnosed patients.


The newer types of treatments that doctors are using to battle cancer are targeted therapy and immunotherapy. Targeted therapy is a personalized medicine approach that targets the mutations that are unique to a patient’s specific tumor. Immunotherapy is a type of cancer treatment that is designed to utilize a patient’s own immune system to kill cancer cells. Targeted therapy and immunotherapy were not available to lung cancer patients 5-10 years ago showing the great strides that are being made in the treatment of lung cancer patients.


But even with these new precise treatments providing so much hope to lung cancer patients – there are still many unanswered questions and these treatments do not work for all lung cancer patients. Researchers are on the precipice of lung cancer breakthroughs and Lung Cancer Foundation of America works to fund these lifesaving treatments. Your help is needed to make sure these advances in treatment come to fruition.


During this tour, Dr. Julie Brahmer, oncologist and renowned lung cancer researcher at Johns Hopkins and Barbara Marder, a lung cancer patient will discuss treatment breakthroughs in the battle against lung cancer and how the Lung Cancer Foundation of America is working to fund life-saving research. Grandmother and adventurer, Barbara Marder, was diagnosed with lung cancer 4-years ago. She responded well to initial chemotherapy but the cancer came back. Because she donated her kidney to her husband, she was not a good candidate for chemotherapy a second time. She was accepted into an immunotherapy clinical trial and today, her tumors are gone – an outcome she considers to be a miracle. Together, she and Dr. Brahmer will share stories of hope and ways your audience can become involved in raising money to help cure lung cancer through LCFA’s 30 Days 30 Ways campaign.